Modulation/physiology of calcium channel sub-types in neurosecretory terminals
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
The hypothalamic-neurohypophysial system (HNS) controls diuresis and parturition through the release of arginine-vasopressin (AVP) and oxytocin (OT). These neuropeptides are chiefly synthesized in hypothalamic magnocellular somata in the supraoptic and paraventricular nuclei and are released into the blood stream from terminals in the neurohypophysis. These HNS neurons develop specific electrical activity (bursts) in response to various physiological stimuli. The release of AVP and OT at the level of neurohypophysis is directly linked not only to their different burst patterns, but is also regulated by the activity of a number of voltage-dependent channels present in the HNS nerve terminals and by feedback modulators. We found that there is a different complement of voltage-gated Ca2+ channels (VGCC) in the two types of HNS terminals: L, N, and Q in vasopressinergic terminals vs. L, N, and R in oxytocinergic terminals. These channels, however, do not have sufficiently distinct properties to explain the differences in release efficacy of the specific burst patterns. However, feedback by both opioids and ATP specifically modulate different types of VGCC and hence the amount of AVP and/or OT being released. Opioid receptors have been identified in both AVP and OT terminals. In OT terminals, μ-receptor agonists inhibit all VGCC (particularly R-type), whereas, they induce a limited block of L-, and P/Q-type channels, coupled to an unusual potentiation of the N-type Ca2+ current in the AVP terminals. In contrast, the N-type Ca2+ current can be inhibited by adenosine via A1 receptors leading to the decreased release of both AVP and OT. Furthermore, ATP evokes an inactivating Ca2+/Na+-current in HNS terminals able to potentiate AVP release through the activation of P2X2, P2X3, P2X4 and P2X7 receptors. In OT terminals, however, only the latter receptor type is probably present. We conclude by proposing a model that can explain how purinergic and/or opioid feedback modulation during bursts can mediate differences in the control of neurohypophysial AVP vs. OT release.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Adenosine Receptors as Therapeutic Targets
Jacobson, K. A., & Gao, Z.-G. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1983 · Cited by 1,431 · cited 1×
“There is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cerebral and cardiac ischemic diseases, sleep disorders, immune and inflammatory disorders and cancer [98].”
BackgroundCD38 is critical for social behaviour by regulating oxytocin secretion
Jin, D., Liu, H.-X., Hirai, H., Torashima, T., Nagai, T., Lopatina, O., Shnayder, N. A., Yamada, K., Noda, M., Seike, T., et al. (2007) · Nature · doi:10.1038/nature05526 · Cited by 665 · cited 1×
“Both hormones may also be central neurotransmitters and have been implicated in sexual behavior [22], stress, learning, memory processes [23,24], the development and maintenance of tolerance to ethanol [25], and also in several pathophysiological functions [24].”
BackgroundDeuchars, S. A., Atkinson, L., Brooke, R. E., Musa, H., Milligan, C. J., Batten, T. F. C., Buckley, N. J., Parson, S. H., & Deuchars, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-18-07143.2001 · Cited by 287 · cited 1×
“The importance of ATP as a neurotransmitter is demonstrated by its involvement in multiple processes throughout the nervous system including modulation of long-term potentiation, pain transduction, bladder control, modulation of vascular tone, and control of the gastrointestinal system [80].”
BackgroundRelease of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats
Moos, F., Poulain, D. A., Rodriguez, F., Guern�, Y., Vincent, J. D., & Richard, P. (1989) · Experimental Brain Research · doi:10.1007/bf00248916 · Cited by 221 · cited 2×
“In contrast, during a physiological OT-like burst (50–200 Hz freuency [113]) co-released ATP probably does not have a positive eedback effect on OT release since those terminals only express he less-sensitive P2X7 receptor (Fig.”
Background
Cited by
Neuropeptide Transmission in Brain Circuits
van den Pol, A. N. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.014 · Cited by 810
“Finally, ATP coreleased from magnocellular neurons exerts different feedback effects on axon terminals and cell bodies, potentially differentially regulating peptide release, in part due to different sets of ATP receptors on axons and cell bodies (Lemos et al, 2012).”
BackgroundP2X7 receptor: an emerging target in central nervous system diseases
Sperlágh, B., & Illes, P. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.08.002 · Cited by 390
Farooq, R. K., Tanti, A., Ainouche, S., Roger, S., Belzung, C., & Camus, V. (2018) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2018.07.016 · Cited by 83
Segregation of calcium signalling mechanisms in magnocellular neurones and terminals
Dayanithi, G., Forostyak, O., Ueta, Y., Verkhratsky, A., & Toescu, E. C. (2012) · Cell Calcium · doi:10.1016/j.ceca.2012.02.002 · Cited by 38
Self-citation
Metadata
- Authors
- Lemos, J. R., Ortiz-Miranda, S. I., Cuadra, A. E., Velázquez-Marrero, C., Custer, E. E., Dad, T., & Dayanithi, G.
- Venue
- Cell Calcium
- Publisher
- Elsevier BV
- Published
- 2012-03
- Volume
- 51
- Issue
- 3-4
- Pages
- 284-292
- ISSN
- 0143-4160 (ISSN-L)
- OpenAlex
- W1985635495
- Cited by
- 47
- References
- 5
- FWCI
- 2.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.